Chromium(V) is produced upon reduction of chromate by mitochondrial electron transport chain complexes
- 1 May 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 10 (5) , 913-920
- https://doi.org/10.1093/carcin/10.5.913
Abstract
Incubation of chromate with isolated rat liver submito-chondrial particles under anaerobic conditions in vitro results in reduction of chromium(VI) and formation of chromium(V). In the presence of NADH, submitochondrial particles (SMPs) were active in reducing chromate as shown by UV-vis spectro-scopic studies, and forming a chromium(V) species which was detectable by electron paramagnetic resonance spectroscopy. In the presence of succinate, SMPs were less effective in reducing chromate and forming chromium(V) relative to their NADH-dependent activity. However, SMPs showed a higher rate of oxygen depletion with NADH as compared to succinate as substrate, suggesting that differences in the NADH-dependent versus succinate-dependent chromate-reductase activity of SMPs is probably due to differences in efficiency of electron donation by succinate and NADH. The use of specific electron transport chain inhibitors allowed the sites of chromium(VI) reduction and chromium(V) formation in SMPs to be determined. Rotenone, antimycin and cyanide all produced ∼40% inhibition of the NADH-dependent chromate-reductase activity. Thus, complex I (NADH: ubi-quinone oxidoreductase) appears to be responsible for the inhibitor-insensitive, and complex IV (ferrocytochrome c:oxygen oxidoreductase) for the inhibitor-sensitive NADH-dependent chromium(VI) reduction and chromium(V) formation. Cyanide and antimycin produced ∼50% inhibition of the succinate-dependent chromate-reductase activity of SMPs, while no detectable inhibition was observed with rotenone. These results confirm the chromate-reductase activity of complex IV, and suggest that complex II (succinate: ubiquinone oxidoreductase) is responsible for the inhibitor-insensitive succinate-dependent chromate-reductase activity of SMPs. Since chromium(VI) is effectively metabolized by electron transport chain complexes of the mito-chondrial inner membrane in vitro, and chromium(V) is formed as an intermediate in the process, mitochondria may play a role in chromium(VI) carcinogenesis.Keywords
This publication has 12 references indexed in Scilit:
- Chromate reduction by rabbit liver aldehyde oxidaseBiochemical and Biophysical Research Communications, 1986
- Disposition of a soluble chromate in the isolated perfused rat liverXenobiotica, 1986
- Modification of chromium(VI)-induced DNA damage by glutathione and cytochromes P-450 in chicken embryo hepatocytes.Proceedings of the National Academy of Sciences, 1985
- Inhibitory action of hexavalent chromium (Cr(VI)) on the mitochondrial respiration and a possible coupling to the reduction of Cr(VI)Biochemical Pharmacology, 1984
- The interaction of chromium with nucleic acidsChemico-Biological Interactions, 1983
- Electron-transport cytochrome P-450 system is involved in the microsomal metabolism of the carcinogen chromateJournal of Inorganic Biochemistry, 1981
- The time-related subcellular distribution of chromium in the rat liver cell after intravenous administration of Na2 51CrO4Biological Trace Element Research, 1979
- Toxic and mutagenic effects of carcinogens on the mitochondria of Saccharomyces cerevisiaeMolecular Genetics and Genomics, 1979
- Metabolism of the carcinogen chromate by rat liver microsomesBiochemical and Biophysical Research Communications, 1978
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951